- Insilico Medicine🔍
- Insilico Medicine Uses Generative AI to Accelerate Drug Discovery🔍
- Insilico Medicine 🔍
- An AI|driven "factory of drugs" claims to have hit a big milestone🔍
- Exelixis and Insilico Medicine Enter into Exclusive Global License ...🔍
- Insilico Medicine founder and CEO Alex Zhavor🔍
- Insilico reveals a 'soup to nuts' process for AI|generated lung fibrosis ...🔍
- Insilico Medicine School🔍
Insilico Medicine
Artificial Intelligence for Drug Discovery and Aging Research.
Insilico Medicine ... For the general use of computer simulation in medicine, see In silico medicine. ... Insilico Medicine is a biotechnology company based in Pak ...
Insilico Medicine | 59420 followers on LinkedIn. #insilicomeds, #drugdiscovery, #ai, #GANs, #GANs-RL, #DL #aging, #longevity | Insilico Medicine, ...
Insilico Medicine Uses Generative AI to Accelerate Drug Discovery
A drug candidate discovered using its AI platform is now entering Phase 2 clinical trials to treat idiopathic pulmonary fibrosis.
Insilico Medicine (@InSilicoMeds) / X
Insilico Medicine is a clinical-stage AI-driven biotech company dedicated to extending human productive longevity by transforming drug discovery with AI.
Insilico: linking target discovery and generative chemistry AI ... - Nature
Insilico validated its AI platform's end-to-end discovery capabilities in a project to create a drug for the lung condition idiopathic pulmonary fibrosis (IPF).
Insilico Medicine - The World Economic Forum
The World Economic Forum is an independent international organization committed to improving the state of the world by engaging business, political, ...
An AI-driven "factory of drugs" claims to have hit a big milestone
Now he says his company, Insilico Medicine, has created the first “true AI drug” that's advanced to a test of whether it can cure a fatal lung ...
Insilico Medicine | Fierce Pharma
When people talk about AI changing the world, they may not know it yet, but they're talking about Insilico Medicine.The company started with a focus on ...
Exelixis and Insilico Medicine Enter into Exclusive Global License ...
“ISM3091 is the third clinical-stage program made possible by Chemistry42, Insilico Medicine's generative AI platform for small molecule drug ...
Insilico Medicine founder and CEO Alex Zhavor - EurekAlert!
Alex Zhavoronkov, PhD, founder and co-CEO of Insilico Medicine will be attending the AAIH Annual Members' Meeting on the Genentech Campus in South San ...
Insilico Medicine - 10 Years of AI Drug Discovery Innovation
Insilico Medicine was born at the Emerging Technology Centers in Baltimore in 2014 where founder and co-CEO Alex Zhavoronkov first began ...
Insilico reveals a 'soup to nuts' process for AI-generated lung fibrosis ...
Insilico Medicine, a developer of artificial intelligence tools for drug discovery, has mapped out its process for making an experimental drug for idiopathic ...
Insilico Medicine. 3.53K subscribers. InClinico - a platform for clinical leaders to assess trial risk and aid in portfolio triage. Insilico Medicine. Search.
Insilico Medicine - Pharmaceutical Technology
Insilico Medicine Job function: Administrative, Advertising/Marketing/PR/Product/Brand, Audit/Accounting/Finance, Board Level Management, Buyer/Purchasing/ ...
Insilico Medicine - Warburg Pincus
Insilico Medicine ... It is developing breakthrough solutions for the discovery and development of innovative drugs for cancer, fibrosis, infectious diseases, ...
Insilico Medicine School: Drug Target Identification
The course is especially suitable for students pursuing a degree in molecular biology, chemistry, or related fields who want to understand the aspects of ...
Insilico Medicine unveils first AI-generated and AI-discovered drug ...
Startup Insilico Medicine announced it has created the first drug discovered and generated by AI, which is now in Phase II clinical trials.
InSilico Medicine Hong Kong Limited
The company is betting on the innovative pharmaceutical industry in Greater China and established the HQ in Hong Kong and R&D offices in Taipei. It has a close ...
Insilico and NVIDIA unveil new LLM transformer for solving ...
Insilico Medicine is a pioneer in using generative AI for drug discovery and development. The Company first described the concept of using ...
Insilico Medicine
Biotechnology companyInsilico Medicine is a biotechnology company based in Pak Shek Kok, Hong Kong in Hong Kong Science Park near the Chinese University of Hong Kong, and in New York, at The Cure by Deerfield.